Rocket Lab at a Crossroads: Technical Support Meets Fundamental Transformation as Analysts Split on Iridium Bet
Veröffentlicht: 16.07.2026 um 03:11 Uhr, Redaktion boerse-global.deRocket Lab’s stock is hovering around its 200-day moving average — a line that chartists view as a make-or-break level — after a brutal pullback from May’s all-time high. The shares closed Wednesday at $78.19, just nine cents above that critical threshold of $78.12, while the 30-day loss of 28.43% and a Relative Strength Index of 35.7 signal that the market is skittish, if not oversold. The annualized volatility over the past month stands at nearly 95%, reflecting extreme trading nervousness.
Yet the operational story could hardly be more upbeat. On July 7, Rocket Lab completed the VICTUS-HAZE mission for the U.S. Space Force, launching a satellite into orbit just 16 hours and 42 minutes after receiving the go-ahead — a record for tactical responsive space. Earlier that week, the company conducted a full-duration hot-fire test of the Archimedes vacuum engine, a key milestone for the Neutron rocket program that remains on track for a debut in the fourth quarter of 2026.
The divergence between price action and business momentum is largely a reflection of the market’s struggle to digest Rocket Lab’s most ambitious strategic move yet. On June 29, the company announced a definitive agreement to acquire Iridium Communications for $8 billion in a mix of cash and stock, gaining a constellation of 66 active satellites plus 14 spares, along with valuable spectrum rights. The deal transforms Rocket Lab from a pure launch provider into a vertically integrated space infrastructure company, owning not only rockets and spacecraft but also an operational satellite network with an established customer base.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Analysts on Wall Street are divided over the implications. Of the 16 firms covering the stock, 81% still rate it a buy, and none recommend selling. The average price target stands at $117, well above current levels. Citizens analyst Trevor Walsh raised his target, calling the Iridium acquisition a decisive move into higher-value space applications that creates a one-stop shop for launch, satellite manufacturing, spectrum, and communications. Roth Capital’s Suji Desilva echoed that view, describing the deal as transformative. But Piper Sandler this week launched coverage with a Neutral rating, citing balanced risks and rewards, while other houses have maintained Hold ratings, pointing to execution challenges in integrating Iridium and potential delays in the Neutron program.
The company’s financials offer little reason for concern. In the first quarter of 2026, Rocket Lab reported record revenue of $200.3 million, up 63.5% year-over-year, with a GAAP net loss narrowing to $45 million and adjusted EBITDA losses shrinking to $11.8 million. The backlog swelled to $2.2 billion, a 108% jump from a year earlier and 20.2% sequentially. Management expects second-quarter revenue between $225 million and $240 million, with an EBITDA loss of $20 million to $26 million.
Against that backdrop, the stock’s slide looks like a technical correction rather than a fundamental repudiation. Since hitting a 52-week high of $151.00 on May 27, the shares have fallen by more than 48%. The weekly loss of 6.19% extends a month-long sell-off that has erased much of the year’s gains — though the stock still shows a 46% advance for the first half of 2026 and is up over 75% from a year ago. The market capitalization stands at approximately €44.21 billion.
Whether the 200-day moving average holds will likely determine the next leg. Historically, Rocket Lab shares have often used this line as a springboard for sharp recoveries rather than a prelude to further declines. The decision now hinges on whether the promise of an integrated space infrastructure business — complete with a new rocket, a satellite network, and growing national security contracts — outweighs the near-term uncertainty of absorbing a multibillion-dollar acquisition and delivering Neutron on schedule. For a stock that has already halved from its peak, the floor may finally be in sight.
Ad
Rocket Lab USA Stock: New Analysis - 16 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
